| NUDT1-positive (n = 31) No. of patients (%) | NUDT1-negative (n = 9) No. of patients (%) | P value |
---|---|---|---|
Gender | Â | Â | 1.000 |
 Male | 22 (71.0) | 7 (77.8) |  |
 Female | 9 (29.0) | 2 (22.2) |  |
Age | Â | Â | 1.000 |
 ≤ 65 | 26 (83.9) | 7 (77.8) |  |
 > 65 | 5 (16.1) | 2 (22.2) |  |
Borrmann | Â | Â | 1.000 |
 Type I | 1 (3.2) | 0 (0.0) |  |
 Type II | 17 (54.9) | 5 (55.6) |  |
 Type III | 12 (38.7) | 4 (44.4) |  |
 Type IV | 1 (3.2) | 0 (0.0) |  |
Differentiation | Â | Â | 0.643 |
 Well/moderately | 8 (25.8) | 1 (11.1) |  |
 Poorly | 23 (74.2) | 8 (88.9) |  |
T stage | Â | Â | 0.004 |
 T1a/T1b | 0 (0.0) | 2 (22.2) |  |
 T2 | 1 (3.2) | 2 (22.2) |  |
 T3 | 1 (3.2) | 1 (11.1) |  |
 T4a | 29 (93.6) | 4 (44.5) |  |
N stage | Â | Â | 0.157 |
 N0 | 12 (38.7) | 2 (22.2) |  |
 N1 | 2 (6.5) | 3 (33.3) |  |
 N2 | 8 (25.8) | 3 (33.3) |  |
 N3a/N3b | 9 (29.0) | 1 (11.2) |  |